Sign in Create account

Healthcare Global Enterprises Limited

Healthcare · Healthcare Services

NSE: HCG BSE: 539787
₹666.05
▼ -37.55 (-5.34%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
31/100
Weak
Valuation
22/100
Expensive
Momentum
30/100
Neutral

QVM read Mixed signals Quality Weak, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹9,944 Cr
PE (TTM)
569.3
Industry median 50.2 (44 companies)
Price to Book
7.1
PEG (TTM)
1.8
Institutions holding %
21.94%
FII + DII, latest filed period
Piotroski Score
6
Relative return vs Nifty50, qtr %
10.6
Relative return vs Sector, qtr %
7.8
Free Cash Flow
₹55 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
48.00%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
489.73%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
11.42%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
61.74%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
15.15%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.09
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.65
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
1.14
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
1.48%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
7.76%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
6.77%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
0.58%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
6.87%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
1.62%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 7 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 6)
  • No Debt to equity is below 0.5 (0.65)
  • No Return on equity is 15% or more (1.6%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (5.2% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.3%
Low 660.5000 · High 710.0000
1W return
-6.5%
Low 660.5000 · High 714.4000
1M return
-9.2%
Low 644.9500 · High 737.9500
52W return
2.5%
Low 513.3000 · High 804.6500
Lifetime High ₹776.3000 (Oct. 29, 2025)
Lifetime Low ₹66.2500 (April 13, 2020)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish5
5D
688.8
10D
693.8
20D
696.9
50D
690.4
100D
672.0
200D
634.5

Delivery and volume

Day avg. delivery
61.1%
Week avg. delivery
59.4%
Month avg. delivery
75.4%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

678.85
Pivot
First resistance697.20
Second resistance728.35
Third resistance746.70
First support647.70
Second support629.35
Third support598.20
Day RSI40.1
Day MFI47.3
Day MACD-2.29
Day MACD signal0.04

Beta

1M0.62
3M0.45
1Y0.71
3Y0.60

Price change analysis

↓ -9.2%
Over 1 Month
LowHigh
644.95737.95
↑ 5.1%
Over 3 Months
LowHigh
626.10775.00
↑ 24.5%
Over 6 Months
LowHigh
516.85775.00
↑ 2.5%
Over 1 Year
LowHigh
513.30804.65
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 569.3 (own history: 139.0–13552.5)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹377 Cr
Net profit (June 30, 2026)
₹6 Cr
Basic EPS (June 30, 2026)
₹0.3700

Ranks #17 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter64.21%
  • Mutual funds15.43%
  • FII/FPI2.74%
  • Other DII3.77%
  • Public13.85%

Largest holders

NameCategoryShares %Shares
HECTOR ASIA HOLDINGS II PTE. LTD.Promoter54.2700%81027087
B S AJAIKUMARPromoter9.3000%13877697
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA ELSPublic5.8800%8780023
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL FUNDPublic3.5800%5339759
TATA MUTUAL FUND - TATA ELSS FUNDPublic3.0300%4518589

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 64.21% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 2.75% to 2.74% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 15.31% to 15.43% in Jun 2026 qtr

11 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 331 insider trades, 56 SAST, 5 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
31 Mar 2026 ASMITHA AJAIKUMAR Promoter group Buy 0 ₹0
31 Mar 2026 AAGNIKA AJAIKUMAR Promoter group Buy 0 ₹0
31 Mar 2026 Hector Asia Holdings II Pte. Ltd. Promoter Buy 0 ₹0
31 Mar 2026 ANJALI AJAIKUMAR ROSSI Promoter group Buy 0 ₹0
31 Mar 2026 Srinivasa Raghavan Employee / designated person Buy 0 ₹0
31 Mar 2026 BHAGYA A AJAIKUMAR Promoter group Buy 0 ₹0
31 Mar 2026 Dr B S Ajaikumar Promoter Buy 0 ₹0
31 Mar 2026 CATALYST TRUSTEESHIP LIMITED Promoter Buy 0 ₹0
31 Mar 2026 Bharatsinh S Gadhavi Employee / designated person Sell 0 ₹0
28 Mar 2026 Bharatsinh S Gadhavi Employee / designated person Sell 0 ₹0

All insider and SAST disclosures →

Deals (Bulk & Block)

All 60 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
10 Sep 2025 PLUTUS WEALTH MANAGEMENT LLP Block Buy 720,000 695.0000 NSE
10 Sep 2025 NIPPON INDIA MUTUAL FUND Block Buy 4,400,000 695.0000 NSE
10 Sep 2025 MOTILAL OSWAL MUTUAL FUND Block Buy 300,000 695.0000 NSE
10 Sep 2025 MORGAN STANLEY ASIA SINGAPORE PTE Block Buy 880,000 695.0000 NSE
10 Sep 2025 ACESO COMPANY PTE LTD. Block Sell 6,300,000 695.0000 NSE
10 Sep 2025 PLUTUS WEALTH MANAGEMENT LLP Bulk Buy 720,000 695.0000 NSE
10 Sep 2025 NIPPON INDIA MUTUAL FUND Bulk Buy 4,400,000 695.0000 NSE
10 Sep 2025 MORGAN STANLEY ASIA SINGAPORE PTE Bulk Buy 880,000 695.0000 NSE
10 Sep 2025 AXIS MUTUAL FUND Bulk Buy 952,700 695.0000 NSE
10 Sep 2025 ACESO COMPANY PTE LTD. Bulk Sell 6,300,000 695.0000 NSE

All bulk and block deals →

Corporate Actions

Full history (7 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
2 Mar 2026RIGHTSRights 1:17 @ Premium Rs 502/-
22 Sep 2022OTHERAnnual General Meeting
23 Sep 2021OTHER Annual General Meeting
19 Sep 2019OTHER Annual General Meeting
19 Sep 2018OTHER Annual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
6 Aug 2026 Financial Results/Other business matters Yes
19 May 2026 Financial Results/Other business matters Yes
24 Feb 2026 Fund Raising —
17 Feb 2026 Fund Raising —
5 Feb 2026 Financial Results/Other business matters Yes

Corporate Announcements

All 857 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Trading Window Healthcare Global Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
30 Sep 2026 Insider Trading / SAST HealthCare Global Enterprises Ltd - 539787 - Closure of Trading Window
18 Sep 2026 Shareholders meeting Healthcare Global Enterprises Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 18, 2026. Further, the company has informed the Exchange regarding voting results.
18 Sep 2026 Shareholders meeting Healthcare Global Enterprises Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 18, 2026
17 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Healthcare Global Enterprises Limited has informed the Exchange about Schedule of meet
16 Sep 2026 Company Update HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Healthcare Global Enterprises Limited has informed the Exchange about Intimation of Schedule of meeting with Institutional investors at Mumbai.
9 Sep 2026 Company Update HealthCare Global Enterprises Ltd - 539787 - Intimation Of Grant Of Employee Stock Options Under Healthcare Global Enterprises Limited- Employee Stock Option Scheme, 2026
9 Sep 2026 Options to purchase securities Healthcare Global Enterprises Limited has informed the Exchange about grant of Employee Stock Options under HealthCare Global Enterprises Limited- Employee Stock Option Scheme, 2026
28 Aug 2026 General Updates Healthcare Global Enterprises Limited has informed the Exchange about Letter to Members of the Company containing weblink and path of Integrated Annual Report for the Financial Year 2025-26.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong revenue growth YoY (15.2%)

Weaknesses

  • Low Return on Equity (1.6%)
  • Thin net profit margin (1.5%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (569.3) -- priced for continued strong execution
  • Weak interest coverage (1.1x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Healthcare Global Enterprises Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.